Proteomics Market to Cross $3.6 Billion by 2010, According to New Report by Global Industry Analysts, Inc.
Proteomics has risen from the point where genomics studies plateaued. The research stream has become the current spotlight for pharmaceutical and biotechnology companies as it opens new roads to precision medication and customized diagnosis and treatment. Global proteomics market is projected to cross US$3.6 billion by 2010.
San Jose, California (PRWEB) July 17, 2007 -- The shift from genomics to proteomics paves way for technological advancements assisting drug discovery researchers by offering added sensitivity, increased throughput and increased resolution from traditional protein research tools. Additionally, the shift in focus also enhances the number of assays requiring protein sample preparation. A major market growth driver is the explosion in scientific discoveries arising from the human genome project and from advances in high-throughput technologies for protein studies. In addition NIH funding for research and from sustained pharmaceutical and biotechnology industry interest in drug discovery is another major reason for this trend.
Expression proteomics market, the largest segment, is estimated at US$1.9 billion in 2007. However, functional proteomics market is expected to spearhead, advancing at a compound annual rate of 25.3% over the review period 2003-2010. The United States and Europe constitute the leading markets for proteomics, accounting for more than 3/4ths of the global market in 2007. Proteomics market in Rest of World comprising select countries of Asia-Pacific and Latin America is estimated at US$81 million in 2007. China and Taiwan are predominant producers of instruments that aid in proteomics research. United Kingdom constitutes one of the leading markets for proteomics in Europe, with an estimated market share of 25% of the European market in 2007.
Products that are direct derivatives of this technology are yet to take shape and hence the industry is measured either by amount of research and development expenditure or by trends in contributing industries. These would include bioinstrumentation, laboratory supplies and services, and bioinformatics. Other significant factors influencing proteomics market, include protein biochips, microfluidics and Micro Electro-Mechanical Systems (MEMS), and nanotechnology.
Major industry participants profiled in the study comprise Agilent Technologies, Applied Biosystems, Biacore International AB, Bio-Rad Laboratories, Dionex Corporation, GE Healthcare, Invitrogen Corporation, PerkinElmer, Proteome Systems Ltd., Shimadzu Biotech, and Thermo Fisher Scientific.
The report titled "Proteomics: A Global Strategic Business Report" published by Global Industry Analysts, Inc. provides a comprehensive insight into the genesis of proteomics, factors influencing the market, growth drivers, and major challenges. The study also provides a peek into encapsulated trends, search for tools to accelerate drug discovery ends with proteomics, international initiatives to boost proteomics research, and its gaining prominence in cancer drug discovery. Know more about the current proteomics scenario and where the technology is heading to from this detailed report. The study also focuses on recent research and development activities, and strategic corporate activity of major market participants.
For more details of this research report please visit www.strategyr.com/MCP-1029.asp
About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a reputed publisher of off-the-shelf market research. Founded in 1987, the company is globally recognized as one of the world's largest market research publishers. The company employs more than 700 people worldwide and publishes more than 880 full-scale research reports each year. Additionally, the company also offers a range of more than 60,000 smaller research products including company reports, market trend reports and industry reports encompassing all major industries worldwide.
Global Industry Analysts, Inc.
Telephone 408-528-9966
Fax 408-528-9977
Web Site www.StrategyR.com
###
Post Comment:
Trackback URL: http://www.prweb.com/pingpr.php/U2luZy1QaWdnLVN1bW0tUGlnZy1UaGlyLVplcm8=
Bookmark -
Del.icio.us |
Furl It |
Technorati |
Ask |
MyWeb |
Propeller |
Live Bookmarks |
Newsvine |
TailRank |
Reddit |
Slashdot |
Digg |
Stumbleupon |
Google Bookmarks |
Sphere |
Blink It |
Spurl
|
